Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,300,445
-$3,705,730 QoQ
Shares Held
127,131
-14.7% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#60
of 274 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. CELC ranks #26 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in CELC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,300,445 | 127,131 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,006,175 | 148,994 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $14,860,661 | 148,994 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||